(CS) AXA - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000120628
Stock:
Total Rating 42
Risk 77
Buy Signal -0.74
| Risk 5d forecast | |
|---|---|
| Volatility | 21.3% |
| Relative Tail Risk | 4.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | 2.19 |
| Character TTM | |
|---|---|
| Beta | 0.352 |
| Beta Downside | 0.556 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.69% |
| CAGR/Max DD | 1.55 |
Description: CS AXA
AXA SA, through its subsidiaries, insurance, asset management, and banking services worldwide. The company operates through six segments: France, Europe, AXA XL, Asia, Africa & EME-LATAM, AXA Investment Managers, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products. The company also provides protection and retirement products for individual and professional customers; reinsurance coverages; property, primary and excess casualty, excess and surplus lines, environmental liability, professional liability, construction, marine, energy, aviation and satellite, fine art and specie, livestock and aquaculture, accident and health, and crisis management. In addition, it offers reinsurance solutions with casualty, property risk, property catastrophe, specialty, and other reinsurance; proportional and non-proportional, and facultative reinsurance; risk management solutions and consulting services; integrated ecosystem combining medical assets with insurance services, which includes onsite services in clinics, remote teleconsultation and digital services, and home services; travel insurance and assistance services, as well as AXA Multilink platform; mobility virtual payment card; parametric insurance; and parametric flight delay product and an eSim card. Further, the company provides asset management services in the various asset classes and multi manager solutions. Additionally, it offers motor, household, property and general liability, health, term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products for retail/individual and commercial/group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 13.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.73 > 1.0 |
| NWC/Revenue: 210.0% < 20% (prev -130.9%; Δ 340.9% < -1%) |
| CFO/TA 0.04 > 3% & CFO 28.20b > Net Income 13.00b |
| Net Debt (42.87b) to EBITDA (20.25b): 2.12 < 3 |
| Current Ratio: 24.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.16b) vs 12m ago -3.78% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 24.48% > 50% (prev 21.31%; Δ 3.17% > 0%) |
| Interest Coverage Ratio: 12.67 > 6 (EBITDA TTM 20.25b / Interest Expense TTM 1.21b) |
Altman Z'' 3.77
| A: 0.51 (Total Current Assets 343.47b - Total Current Liabilities 14.14b) / Total Assets 645.57b |
| B: 0.06 (Retained Earnings 35.58b / Total Assets 645.57b) |
| C: 0.02 (EBIT TTM 15.32b / Avg Total Assets 640.57b) |
| D: 0.08 (Book Value of Equity 45.49b / Total Liabilities 588.98b) |
| Altman-Z'' Score: 3.77 = AA |
Beneish M -3.34
| DSRI: 0.70 (Receivables 9.90b/12.17b, Revenue 156.81b/135.46b) |
| GMI: 0.87 (GM 108.8% / 94.50%) |
| AQI: 0.93 (AQ_t 0.46 / AQ_t-1 0.50) |
| SGI: 1.16 (Revenue 156.81b / 135.46b) |
| TATA: -0.02 (NI 13.00b - CFO 28.20b) / TA 645.57b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of CS shares?
As of March 03, 2026, the stock is trading at EUR 40.53 with a total of 5,391,693 shares traded.
Over the past week, the price has changed by +1.78%, over one month by +4.11%, over three months by +5.03% and over the past year by +11.92%.
Over the past week, the price has changed by +1.78%, over one month by +4.11%, over three months by +5.03% and over the past year by +11.92%.
Is CS a buy, sell or hold?
AXA has no consensus analysts rating.
What are the forecasts/targets for the CS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.3 | 11.7% |
| Analysts Target Price | - | - |
CS Fundamental Data Overview February 27, 2026
Market Cap USD = 99.14b (84.06b EUR * 1.1794 EUR.USD)
P/E Trailing = 12.2219
P/E Forward = 9.8232
P/S = 0.9019
P/B = 1.8937
P/EG = 1.2122
Revenue TTM = 156.81b EUR
EBIT TTM = 15.32b EUR
EBITDA TTM = 20.25b EUR
Long Term Debt = 29.54b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last fiscal year)
Debt = 65.32b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 42.87b EUR (from netDebt column, last quarter)
Enterprise Value = 126.93b EUR (84.06b + Debt 65.32b - CCE 22.45b)
Interest Coverage Ratio = 12.67 (Ebit TTM 15.32b / Interest Expense TTM 1.21b)
EV/FCF = 4.66x (Enterprise Value 126.93b / FCF TTM 27.26b)
FCF Yield = 21.47% (FCF TTM 27.26b / Enterprise Value 126.93b)
FCF Margin = 17.38% (FCF TTM 27.26b / Revenue TTM 156.81b)
Net Margin = 8.29% (Net Income TTM 13.00b / Revenue TTM 156.81b)
Gross Margin = unknown ((Revenue TTM 156.81b - Cost of Revenue TTM -13.79b) / Revenue TTM)
Tobins Q-Ratio = 0.20 (Enterprise Value 126.93b / Total Assets 645.57b)
Interest Expense / Debt = 0.46% (Interest Expense 299.0m / Debt 65.32b)
Taxrate = 25.32% (659.5m / 2.60b)
NOPAT = 11.44b (EBIT 15.32b * (1 - 25.32%))
Current Ratio = 24.30 (Total Current Assets 343.47b / Total Current Liabilities 14.14b)
Debt / Equity = 1.44 (Debt 65.32b / totalStockholderEquity, last quarter 45.49b)
Debt / EBITDA = 2.12 (Net Debt 42.87b / EBITDA 20.25b)
Debt / FCF = 1.57 (Net Debt 42.87b / FCF TTM 27.26b)
Total Stockholder Equity = 45.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.03% (Net Income 13.00b / Total Assets 645.57b)
RoE = 28.73% (Net Income TTM 13.00b / Total Stockholder Equity 45.27b)
RoCE = 20.48% (EBIT 15.32b / Capital Employed (Equity 45.27b + L.T.Debt 29.54b))
RoIC = 9.92% (NOPAT 11.44b / Invested Capital 115.36b)
WACC = 4.21% (E(84.06b)/V(149.38b) * Re(7.21%) + D(65.32b)/V(149.38b) * Rd(0.46%) * (1-Tc(0.25)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.49%
[DCF] Terminal Value 87.94% ; FCFF base≈20.15b ; Y1≈23.56b ; Y5≈35.43b
[DCF] Fair Price = 475.8 (EV 1037.49b - Net Debt 42.87b = Equity 994.62b / Shares 2.09b; r=5.90% [WACC]; 5y FCF grow 17.97% → 2.90% )
EPS Correlation: -4.58 | EPS CAGR: -58.16% | SUE: 0.0 | # QB: 0
Revenue Correlation: -14.86 | Revenue CAGR: -6.30% | SUE: -0.72 | # QB: 0
EPS next Year (2026-12-31): EPS=4.13 | Chg7d=-0.018 | Chg30d=-0.029 | Revisions Net=+3 | Growth EPS=+5.6% | Growth Revenue=+4.4%
P/E Trailing = 12.2219
P/E Forward = 9.8232
P/S = 0.9019
P/B = 1.8937
P/EG = 1.2122
Revenue TTM = 156.81b EUR
EBIT TTM = 15.32b EUR
EBITDA TTM = 20.25b EUR
Long Term Debt = 29.54b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last fiscal year)
Debt = 65.32b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 42.87b EUR (from netDebt column, last quarter)
Enterprise Value = 126.93b EUR (84.06b + Debt 65.32b - CCE 22.45b)
Interest Coverage Ratio = 12.67 (Ebit TTM 15.32b / Interest Expense TTM 1.21b)
EV/FCF = 4.66x (Enterprise Value 126.93b / FCF TTM 27.26b)
FCF Yield = 21.47% (FCF TTM 27.26b / Enterprise Value 126.93b)
FCF Margin = 17.38% (FCF TTM 27.26b / Revenue TTM 156.81b)
Net Margin = 8.29% (Net Income TTM 13.00b / Revenue TTM 156.81b)
Gross Margin = unknown ((Revenue TTM 156.81b - Cost of Revenue TTM -13.79b) / Revenue TTM)
Tobins Q-Ratio = 0.20 (Enterprise Value 126.93b / Total Assets 645.57b)
Interest Expense / Debt = 0.46% (Interest Expense 299.0m / Debt 65.32b)
Taxrate = 25.32% (659.5m / 2.60b)
NOPAT = 11.44b (EBIT 15.32b * (1 - 25.32%))
Current Ratio = 24.30 (Total Current Assets 343.47b / Total Current Liabilities 14.14b)
Debt / Equity = 1.44 (Debt 65.32b / totalStockholderEquity, last quarter 45.49b)
Debt / EBITDA = 2.12 (Net Debt 42.87b / EBITDA 20.25b)
Debt / FCF = 1.57 (Net Debt 42.87b / FCF TTM 27.26b)
Total Stockholder Equity = 45.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.03% (Net Income 13.00b / Total Assets 645.57b)
RoE = 28.73% (Net Income TTM 13.00b / Total Stockholder Equity 45.27b)
RoCE = 20.48% (EBIT 15.32b / Capital Employed (Equity 45.27b + L.T.Debt 29.54b))
RoIC = 9.92% (NOPAT 11.44b / Invested Capital 115.36b)
WACC = 4.21% (E(84.06b)/V(149.38b) * Re(7.21%) + D(65.32b)/V(149.38b) * Rd(0.46%) * (1-Tc(0.25)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.49%
[DCF] Terminal Value 87.94% ; FCFF base≈20.15b ; Y1≈23.56b ; Y5≈35.43b
[DCF] Fair Price = 475.8 (EV 1037.49b - Net Debt 42.87b = Equity 994.62b / Shares 2.09b; r=5.90% [WACC]; 5y FCF grow 17.97% → 2.90% )
EPS Correlation: -4.58 | EPS CAGR: -58.16% | SUE: 0.0 | # QB: 0
Revenue Correlation: -14.86 | Revenue CAGR: -6.30% | SUE: -0.72 | # QB: 0
EPS next Year (2026-12-31): EPS=4.13 | Chg7d=-0.018 | Chg30d=-0.029 | Revisions Net=+3 | Growth EPS=+5.6% | Growth Revenue=+4.4%